id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-E-0307-0009,FDA,FDA-2008-E-0307,U.S. Patent & Trademark Office to Johnson & Johnson - Letter,Other,Letter(s),2012-01-10T05:00:00Z,2012,1,2012-01-10T05:00:00Z,,2012-01-10T13:26:09Z,,0,0,0900006480f90856
FDA-2008-E-0307-0008,FDA,FDA-2008-E-0307,Noice of Determination - Letter,Other,LET-Letter,2010-12-23T05:00:00Z,2010,12,,,2010-12-27T18:02:38Z,,0,0,0900006480bbeaf0
FDA-2008-E-0307-0007,FDA,FDA-2008-E-0307,FDA/CDER to US Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-04T05:00:00Z,2010,3,,,2013-07-27T23:10:37Z,,0,0,0900006480ab3b68
FDA-2008-E-0307-0006,FDA,FDA-2008-E-0307,Determination of Regulatory Review Period for Purposes of Patent Extension; INTELENCE,Notice,N-Notice,2009-05-22T04:00:00Z,2009,5,2009-05-22T04:00:00Z,2009-07-22T03:59:59Z,2009-05-22T16:13:35Z,E9-12050,0,0,09000064809ac030
FDA-2008-E-0307-0005,FDA,FDA-2008-E-0307,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2009-01-12T05:00:00Z,2009,1,2009-01-12T05:00:00Z,,2009-01-12T16:09:54Z,,0,0,090000648081ab16
FDA-2008-E-0307-0004,FDA,FDA-2008-E-0307,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2008-10-24T04:00:00Z,2008,10,2008-10-24T04:00:00Z,,2008-10-24T13:05:11Z,,0,0,0900006480777104
FDA-2008-E-0307-0003,FDA,FDA-2008-E-0307,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2008-10-22T04:00:00Z,2008,10,2008-10-22T04:00:00Z,,2008-10-22T19:04:30Z,,0,0,09000064806fcdb6
FDA-2008-E-0307-0002,FDA,FDA-2008-E-0307,USPTO to FDA/CDER - Letter,Other,LET-Letter,2008-07-11T04:00:00Z,2008,7,2008-07-11T04:00:00Z,,2008-07-12T00:07:06Z,,0,0,09000064805f56aa
FDA-2008-E-0307-0001,FDA,FDA-2008-E-0307,"Janssen Pharmaceutica, N.V. - Patent Term Extension Application",Other,APP-Application,2008-07-11T04:00:00Z,2008,7,2008-07-11T04:00:00Z,,2013-08-11T04:25:50Z,,0,0,09000064805f5632